Journal List > J Korean Ophthalmol Soc > v.55(12) > 1009867

Moon, Jang, and Cho: Surgical Outcomes in Epiretinal Membrane According to the Presence of Vitreomacular Traction Syndrome

Abstract

Purpose

To present preoperative macular structure deformities and surgical outcomes in idiopathic epiretinal membrane (ERM) patient according to the presence of vitreomacular traction syndrome (VMTS).

Methods

This retrospective observational study included 54 eyes of 51 patients with idiopathic ERM, who underwent pars plana vitrectomy with ERM and internal limiting membrane (ILM) peeling, and were followed for more than 6 months. Subjects were classified into 2 groups according to the presence of VMTS using preoperative optical coherence tomography (group 1: ERM without VMTS, 29 eyes; group 2: ERM with VMTS, 22 eyes). Preoperative macular structure deformity and surgical outcomes were compared and prognostic factors were analyzed.

Results

Group 1 (ERM without VMTS) included 29 eyes, and group 2 (ERM with VMTS) included 22 eyes. Group 2 had a significantly higher occurrence of lamellar macular hole and a significantly lower preoperative best-corrected visual acuity (BCVA) compared to group 1. However, final postoperative BCVAs were not significantly different between the groups because BCVA changed more in group 2. Preoperative macular structure deformities (irregular retinal surface, retinal thickening, lamellar macular hole, and cystoid macular edema) did not affect visual outcomes. The presence of photoreceptor inner segment/outer segment (IS/OS) junction disruption and preoperative BCVA were highly related with visual outcomes.

Conclusions

BCVA significantly improved in idiopathic ERM patients who underwent pars plana vitrectomy with ERM and ILM peeling regardless of the presence of VMTS. There may be a stronger association of IS/OS junction disruption with visual acuity compared to VMTS in idiopathic ERM surgery.

References

1. Wickham L, Gregor Z. Epiretinal membrane. Ryan SJ, editor. Retina. 5th ed.Baltimore: Elsevier;2013. 3:chap. 116.
2. Kampik A. Pathology of epiretinal membrane, idiopathic macular hole, and vitreomacular traction syndrome. Retina. 2012; 32:S194–8. discussion S198-9.
crossref
3. Zhao F, Gand, orfer A, Haritoglou C, et al. Epiretinal cell proliferation in macular pucker and vitreomacular traction syndrome: analysis of flat-mounted internal limiting membrane specimens. Retina. 2013; 33:77–88.
4. Seo SJ, Lee SJ, Park JM. Surgical outcome according to morphology in epiretinal membrane based on optical coherence tomography (OCT). J Korean Ophthalmol Soc. 2013; 54:736–44.
crossref
5. Lee P, Lee TG, Kim MS, et al. Prognostic factors in vitrectomy for macular epiretinal membrane. J Korean Ophthalmol Soc. 2011; 52:1302–7.
crossref
6. Vinores SA, Campochiaro PA, Conway BP. Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes. Invest Ophthalmol Vis Sci. 1990; 31:14–28.
7. Gupta P, Yee KM, Garcia P, et al. Vitreoschisis in macular diseases. Br J Ophthalmol. 2011; 95:376–80.
crossref
8. Spaide RF. Vitreomacular traction syndrome. Retina. 2012; 32(Suppl 2):S187–90. discussion S190-3.
crossref
9. Koizumi H, Spaide RF, Fisher YL, et al. Three-dimensional evaluation of vitreomacular traction and epiretinal membrane using spectral-domain optical coherence tomography. Am J Ophthalmol. 2008; 145:509–17.
crossref
10. Sonmez K, Capone A Jr, Trese MT, Williams GA. Vitreomacular traction syndrome: impact of anatomical configuration on anatomical and visual outcomes. Retina. 2008; 28:1207–14.
11. Yamada N, Kishi S. Tomographic features and surgical outcomes of vitreomacular traction syndrome. Am J Ophthalmol. 2005; 139:112–7.
crossref
12. Odrobina D, Michalewska Z, Michalewski J, et al. Long-term evaluation of vitreomacular traction disorder in spectral-domain optical coherence tomography. Retina. 2011; 31:324–31.
crossref
13. Bottós JM, Elizalde J, Rodrigues EB, Maia M. Current concepts in vitreomacular traction syndrome. Curr Opin Ophthalmol. 2012; 23:195–201.
crossref
14. Kinoshita T, Kovacs KD, Wagley S, Arroyo JG. Morphologic differences in epiretinal membranes on ocular coherence tomography as a predictive factor for surgical outcome. Retina. 2011; 31:1692–8.
crossref
15. Wong JG, Sachdev N, Beaumont PE, Chang AA. Visual outcomes following vitrectomy and peeling of epiretinal membrane. Clin Experiment Ophthalmol. 2005; 33:373–8.
crossref
16. Lee HJ, Kim HC. The clinical outcome and prognostic factors of vitrectomy for macular epiretinal membranes. J Korean Ophthalmol Soc. 2003; 44:857–64.
17. Kim CH, Kim JI, Cho HY, Kang SW. Correlation between preoperative OCT pattern and visual improvement in macular epiretinal membrane. J Korean Ophthalmol Soc. 2007; 48:75–82.
18. Suh MH, Seo JM, Park KH, Yu HG. Associations between macular findings by optical coherence tomography and visual outcomes after epiretinal membrane removal. Am J Ophthalmol. 2009; 147:473–80.e3.
crossref
19. Ahn SJ, Ahn J, Woo SJ, Park KH. Photoreceptor change and visual outcome after idiopathic epiretinal membrane removal with or without additional internal limiting membrane peeling. Retina. 2014; 34:172–81.
crossref
20. Park DW, Dugel PU, Garda J, et al. Macular pucker removal with and without internal limiting membrane peeling: pilot study. Ophthalmology. 2003; 110:62–4.
crossref
21. Sandali O, El Sanharawi M, Basli E, et al. Epiretinal membrane recurrence: incidence, characteristics, evolution, and preventive and risk factors. Retina. 2013; 33:2032–8.

Figure 1.
Spectral domain optical coherence tomography (SD-OCT) images of 2 groups. (A, B) Epiretinal membrane (ERM) without vitreomacular traction syndrome (VMTS); hyper-reflective ERM above retinal surface and retinal thickening are seen, but posterior hyaloid is not seen. (C, D) ERM with VMTS; posterior hyaloid attached with ERM causing retinal traction and inner retinal plication are seen.
jkos-55-1834f1.tif
Figure 2.
Spectral domain optical coherence tomography (SD-OCT) images of preoperative macular structure deformities. (A) Inner segment/outer segment (IS/OS) junction disruption; white arrow presents hypo-reflective discontinuity in the hyper-reflective IS/OS junction. (B) Irregular retinal surface beneath hyper-reflective epiretinal membrane (ERM) is seen. (C) Diffuse retinal thickening. (D) Cystoid macular edema. (E) Lamellar macular hole at fovea. Photoreceptor layers are intact.
jkos-55-1834f2.tif
Figure 3.
Spectral domain optical coherence tomography (SD-OCT) image changes after surgery of the same eye as in Fig. 1; Epiretinal membrane (ERM) without vitreomacular traction syndrome (VMTS). (A) Preoperative SD-OCT images with visual acuity log MAR 0.52. (B) SD-OCT image at 12 months after operation with visual acuity log MAR 0.30. Foveal contour is not completely recovered but fovea is depressed. White arrow presents damages of nerve fiber layer and ganglion cell layer during internal limiting membrane (ILM) peeling.
jkos-55-1834f3.tif
Figure 4.
Spectral domain optical coherence tomography (SD-OCT) image changes after surgery of the same eye as in Fig. 1; Epiretinal membrane (ERM) with vitreomacular traction syndrome (VMTS). (A) Preoperative SD-OCT images with visual acuity log MAR 0.70. (B) SD-OCT image at 12 months after operation with visual acuity log MAR 0.05. Inner retinal surface is still irregular, but overall retina is remarkably flattened and photoreceptor layers are intact.
jkos-55-1834f4.tif
Table 1.
Patient's demographic findings in 2 groups
Group 1* Group 2 Total p-value
No. of eyes 32 22 54
Sex (M:F) 8:21 8:14 16:35 0.773
Age (years) 69.6 ± 6.3 61.4 ± 11.8 66.2 ± 9.7 0.003§
Duration of symptom (months) 12.3 ± 11.5 7.4 ± 6.4 10.5 ± 10.0 0.248§
Phakic:Pseudophakic 28:4 21:1 49:5 0.638
Surgery (%)
 Combined cataract surgery 28 (87.5) 21 (95.5) 49 (90.7) 0.638
 PPV + ERM removal + ILM peeling 32 (100) 22 (100) 54 (100)
 SF6 gas tamponade 10 (31.3) 17 (77.3) 27 (50.5) 0.002
Follow-up (months) 20.4 ± 14.6 20.9 ± 13.8 20.6 ± 14.2 0.832§

Values are presented as mean ± SD unless otherwise indicated.

PPV = pars plana vitrectomy; ERM = epiretinal membrane; ILM = inner limiting membrane.

* Idiopathic ERM without VMTS;

Idiopathic ERM with vitreomacular traction syndrome (VMTS);

Fisher's exact test;

§ Mann-Whitney test.

Table 2.
Comparisons of preoperative macular structure deformities by OCT in 2 groups
OCT findings Group 1* Group 2 p-value
IS/OS junction disruption (%) 4/32 (12.5) 7/22 (31.8) 0.100§
Presence of irregular retinal surface (%) 12/32 (37.5) 10/22 (45.5) 0.559
Increased retinal thickness (%) 28/32 (87.5) 20/22 (90.9) 0.695§
Presence of cystoid macular edema (%) 5/32 (15.6) 4/22 (18.2) 0.702§
Presence of lamellar macular hole (%) 2/32 (6.3) 10/22 (45.5) 0.002§

OCT = optical coherence tomography; IS/OS = inner segment/outer segment.

* Idiopathic epiretinal membrane (ERM) without vitreomacular traction syndrome (VMTS);

Idiopathic ERM with VMTS;

Chi-Square test;

§ Fisher's exact test.

Table 3.
Comparisons of best corrected visual acuity in 2 groups
Group 1* Group 2 p-value
Preoperative BCVA (log MAR) 0.34 ± 0.24 0.50 ± 0.24 0.010
Final BCVA (log MAR) 0.19 ± 0.21 0.23 ± 0.19 0.258
BCVA change (log MAR) 0.14 ± 0.13 0.26 ± 0.23 0.003
p-value 0.001§ 0.001§

Values are presented as mean ± SD.

BCVA = best corrected visual acuity.

* Idiopathic epiretinal membrane (ERM) without vitreomacular traction syndrome (VMTS);

Idiopathic ERM with VMTS;

Mann-Whitney test;

§ Wilcoxon signed rank test.

Table 4.
Comparisons of central macular thickness in 2 groups
Group 1* Group 2 p-value
Preoperative CMT (μm) 418.8 ± 107 510.6 ± 144.5 0.014
Final CMT (μm) 338.0 ± 83.0 328.5 ± 85.2 0.805
CMT change (μm) 80.8 ± 75.8 182.1 ± 147.6 0.003
p-value 0.001§ 0.001§

Values are presented as mean ± SD.

CMT = central macular thickness.

* Idiopathic epiretinal membrane (ERM) without vitreomacular traction syndrome (VMTS);

Idiopathic ERM with VMTS;

Mann-Whitney test;

§ Wilcoxon signed rank test.

Table 5.
Prognostic factors according to preoperative macular structure deformities by OCT in 2 groups
OCT findings Postoperative BCVA (log MAR)
p-value
≥0.3 (n = 19) <0.3 (n = 35)
IS/OS junction disruption (%) 9/19 (47.4) 2/35 (5.7) 0.000*
Presence of irregular retinal surface (%) 7/19 (36.8) 15/35 (42.9) 0.667
Increased retinal thickness (%) 17/19 (89.5) 29/35 (82.9) 0.698*
Presence of cystoid macular edema (%) 4/19 (21.1) 4/35 (11.4) 0.431*
Presence of lamellar macular hole (%) 5/19 (26.3) 7/35 (20.0) 0.734*

OCT = optical coherence tomography; BCVA = best corrected visual acuity; IS/OS = inner segment/outer segment.

* Fisher's exact test;

Chi-Square test.

Table 6.
Prognostic factors for final BCVA
Factors p-value*
Age 0.220
Sex 0.564
Duration of symptom 0.422
Preoperative BCVA 0.000
Presence of VMTS 0.303
IS/OS junction disruption 0.000
Presence of irregular retinal surface 0.989
Increased retinal thickness 0.379
Presence of lamellar macular hole 0.361
Presence of cystoid macular edema 0.790
SF6 gas tamponade 0.340

BCVA = best corrected visual acuity; VMTS = vitreomacular traction syndrome; IS/OS = inner segment/outer segment.

* Multiple linear regression analysis.

TOOLS
Similar articles